Hemophagocytic Lymphohistiocytosis (HLH)
Why in News?
Hemophagocytic Lymphohistiocytosis (HLH) is prominently in the news following the tragic passing of former Afghanistan international fast bowler Shapoor Zadran, who died at the age of 38 on July 7, 2026, after a aggressive battle with this rare, life-threatening immune system disorder.
About
- Immune system failure: It is a rare hyperinflammatory syndrome where the immune system's "off-switch" fails to function properly.
- Destructive overactivity: Activated immune cells (macrophages and lymphocytes) multiply uncontrollably and mistakenly secrete excessive, toxic cytokines.
- Cellular cannibalism: The term "hemophagocytic" literally means "blood-eating" cells; hyperactive macrophages aggressively engulf and destroy the body's own red blood cells, white blood cells, and platelets.
- Organ damage: The resulting "cytokine storm" spreads widespread inflammation, rapidly damaging healthy tissues and essential organs.
Primary vs. Secondary HLH
- Primary (Familial) HLH: Caused by inherited, recessively passed genetic mutations that disrupt normal cytotoxic lymphocyte function. It typically manifests during infancy or early childhood.
- Secondary (Acquired) HLH: Tends to develop later in life and is triggered by separate underlying medical stimuli.
- Secondary triggers: Common environmental sparks include severe viral infections (like Epstein-Barr virus or Dengue), autoimmune diseases (such as lupus), and blood cancers (like lymphoma).
Common Symptoms
- Persistent, unremittingly high fevers.
- Splenomegaly and hepatomegaly (severe swelling of the spleen and liver).
- Pancytopenia (extremely low levels across all blood cell counts).
- Jaundice (yellowing discoloration of skin and eyes) alongside generalized skin rashes.
- Swollen lymph nodes and easy bruising or bleeding.
- Neurological abnormalities including severe headaches, confusion, seizures, or coma.
Diagnosis and Treatment
- Key biomarker: Measuring extremely elevated levels of ferritin in the blood serves as a vital diagnostic clue for HLH.
- Clinical criteria: Doctors follow strict diagnostic guidelines (HLH-2004 criteria) requiring specific laboratory and bone marrow biopsy confirmations.
- Aggressive management: Treatment demands prompt intervention via high-dose anti-inflammatory steroids, immunosuppressants, and targeted chemotherapy to curb the immune response.
- Curative options: For primary genetic variants, an allogeneic bone marrow or stem cell transplant is required to replace the flawed immune framework.
- Prognosis: Even with cutting-edge critical care, mortality rates remain dangerously high, ranging from 40% to over 70% in untreated or delayed cases.
Download Pdf
